BioXcel Therapeutics Inc — Balance Sheet (NASDAQ:BTAI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 219.94 M239.44 M205.85 M73.7 M38.34 M44.92 M Total liabilities 13.24 M17.77 M129.08 M130.21 M131.44 M140.38 M Total equity 206.7 M221.67 M76.78 M-56.51 M-93.1 M-95.46 M Total liabilities & shareholders' equities 219.94 M239.44 M205.85 M73.7 M38.34 M44.92 M Total debt ——93.05 M100.6 M102.51 M109.59 M Net debt ——-100.67 M35.38 M72.65 M81.18 M

News

BioXcel Therapeutics stock initiated with buy rating at Rodman

BioXcel Therapeutics closes $8M registered direct offering

BioXcel Therapeutics raises $8M in registered direct offering

Why Are BioXcel Therapeutics Shares Down Friday? - BioXcel Therapeutics (NASDAQ:BTAI)

BioXcel reports positive Phase 2 data for opioid withdrawal drug

BioXcel Therapeutics Stock Rallies Opioid Study Success - BioXcel Therapeutics (NASDAQ:BTAI)

BioXcel Therapeutics announces milestone and retention bonuses for key executives

BioXcel Therapeutics submits application to expand IGALMI use for at-home treatment

BioXcel Therapeutics submits sNDA for at-home use of IGALMI

BioXcel plans FDA submission for at-home agitation treatment

BioXcel Therapeutics, Inc. (BTAI) Discussion of Managing Acute Agitation in Schizophrenia and Bipolar Disorders at Home Transcript

BioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Misses Revenue Estimates